1- Sobel J. Vulvovaginal candidosis. Lancet 2007 ; 369 :1961-71
2- Anderson MR et coll. Evaluation of vaginal complaints. JAMA 2004 ;291 :1368-79
3- Croxtall JD, Plosker GL. Sertaconazole : a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009 ;69(3):339-59
4- Sobel JD et coll. Single oral dose fluconazol compared with conventional topical therapy of candida vaginitis. Am J Obstet Gynecol 1995 ; 172 :1263-8
5- Mendling W and the German Society for Gynecology and Obstetrics. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics. Mycoses. 2012 Jul ;55 Suppl 3:1-13.
6- Say J & Jacyntho Cl. Difficult –to- manage vaginitis. Clinical Obstet Gynecol 2005 ; 4 : 753-68
7- Ray D, Goswami R & coll. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. J Infect. 2007 Oct ;55(4):374-7.
8- Trends in Candidal vaginitis Proceedings of thr Royal Society of Medicine 1977 : 70 : Suppl 4
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025